Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) Shares Outstanding (Weighted Average) (2016 - 2025)

Alkermes (ALKS) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $164.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.42% to $164.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $164.7 million through Dec 2025, changed 0.42% year-over-year, with the annual reading at $164.7 million for FY2025, 0.42% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $164.7 million at Alkermes, roughly flat from $165.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $168.3 million in Q2 2024, with the low at $159.6 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $164.1 million, with a median of $164.2 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 2.27% in 2022, then decreased 2.72% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $160.9 million in 2021, then rose by 1.74% to $163.7 million in 2022, then rose by 1.52% to $166.2 million in 2023, then fell by 0.5% to $165.4 million in 2024, then decreased by 0.42% to $164.7 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $164.7 million, $165.1 million, and $164.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.